Business
Supreme Critical Metals Announces Closing of First Tranche of Life Offering, Upsize to Offering and Filing of Amended and Restated Offering Document
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2026) - Supreme Critical Metals Inc., (CSE: CRIT) (FSE: VR6) (OTC Pink: VRCFF) ("Supreme" or the "Company") is pleased to announce it has closed the first tranche of its non-brokered private placement (the "LIFE Offering") financing of up to 10,000,000 units of the Company ("Units") as previously announced in its press release dated January 27, 2026 (the "Initial Press Release"). Any words capitalized but undefined herein shall have the.
About this update from Supreme Critical Metals Inc
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - February 6, 2026) - Supreme Critical Metals Inc., (CSE: CRIT) (FSE: VR6) (OTC Pink: VRCFF) ("Supreme" or the "Company") is pleased to announce it has closed the first tranche of its non-brokered private placement (the "LIFE Offering") financing of up to 10,000,000 units of the Company ("Units") as previously announced in its press release dated January 27, 2026 (the "Initial Press Release"). Any words capitalized but undefined herein shall have the meaning ascribed to such capitalized term in the Initial Press Release.","length":621,"tagName":"p"},{"type":"text","content":"The first tranche closing of the LIFE Offering consisted of the issuance of an aggregate of 9,680,000 Units at a price of $0.10 per Unit. Each Unit consists of one Common Share and one-half of one common share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to acquire one additional Common Share in the capital of the Company at a price of $0.20 for a period of 24 months from the closing of the first tranche of the LIFE Offering.","length":477,"tagName":"p"},{"type":"text","content":"The Company relied on the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions in connection with the distribution of all 9,680,000 free trading Common Shares under tranche one of the LIFE Offering for proceeds of $968,000. The Company paid $49,910 in finder's fees and issued 499,100 finder's warrants (the "Finder's Warrants") in connection with this tranche of the LIFE Offering. The Finder's Warrants entitle the holder thereof to acquire one additional Common Share in the capital of the Company at a price of $0.20 for a period of 24 months from the closing of the first tranche of the LIFE Offering.","length":681,"tagName":"p"},{"type":"text","content":"The issuance of 450,000 Units, in aggregate, to certain insiders of the Company constitutes a "related party transaction" as such term is defined in Multilateral Instrument 61-101 ("MI 61-101"). Pursuant to Sections 5.5(b) and 5.7(1)(a) of MI 61-101, the Company intends to rely on exemptions from the formal valuation and minority shareholder approval requirements, respectively, as the Common Shares t...